bioRxiv ScienceSearch

Biology subjects

Bartsch, F.

Publications and source records attributed to Bartsch, F..

2 recordsLinked to original sources

Model-based characterization of the selectivity of neurons in primary visual cortex

To understand the complexity of stimulus selectivity in primary visual cortex (V1), models constructed to match observed responses to complex time-varying stimuli, instead of to explain responses to simple parametric stimuli, are increasingly used. While such models often can more accurately reflect the computations performed by V1 neurons in more natural visual environments, they do not by themselves provide insight into established measures of V1 neural selectivity such as receptive field size, spatial frequency tuning and phase invariance. Here, we suggest a series of analyses that can be directly applied to encoding models to link complex encoding models to more interpretable aspects of stimulus selectivity, applied to nonlinear models of V1 neurons recorded in awake macaque in response to random bar stimuli. In linking model properties to more classical measurements, we demonstrate several novel aspects of V1 selectivity not available to simpler experimental measurements. For example, we find that individual spatiotemporal elements of the V1 models often have a smaller spatial scale than the overall neuron sensitivity, and that this results in non-trivial tuning to spatial frequencies. Additionally, our proposed measures of nonlinear integration suggest that more classical classifications of V1 neurons into simple versus complex cells are spatial-frequency dependent. In total, rather than obfuscate classical characterizations of V1 neurons, model-based characterizations offer a means to more fully understand their selectivity, and provide a means to link their classical tuning properties to their roles in more complex, natural, visual processing. Significance statementVisual neurons are increasingly being studied with more complex, natural visual stimuli, with increasingly complex models necessary to characterize their response properties. Here, we describe a battery of analyses that relate these more complex models to classical characterizations. Using such model-based characterizations of V1 neurons furthermore yields several new insights into V1 processing not possible to capture in more classical means to measure their visual selectivity.

neuroscience

Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing

Caffeine is by far the most ubiquitous psychostimulant worldwide found in tea, coffee, cocoa, energy drinks, and many other beverages and food. Caffeine is almost exclusively metabolized in the liver by the cytochrome P-450 enzyme system to the main product paraxanthine and the additional products theobromine and theophylline. Besides its stimulating properties, two important applications of caffeine are metabolic phenotyping of cytochrome P450 1A2 (CYP1A2) and liver function testing. An open challenge in this context is to identify underlying causes of the large inter-individual variability in caffeine pharmacokinetics. Data is urgently needed to understand and quantify confounding factors such as lifestyle (e.g. smoking), the effects of drug-caffeine interactions (e.g. medication metabolized via CYP1A2), and the effect of disease. Here we report the first integrative and systematic analysis of data on caffeine pharmacokinetics from 148 publications and provide a comprehensive high-quality data set on the pharmacokinetics of caffeine, caffeine metabolites, and their metabolic ratios in human adults. The data set is enriched by meta-data on the characteristics of studied patient cohorts and subjects (e.g. age, body weight, smoking status, health status), the applied interventions (e.g. dosing, substance, route of application), measured pharmacokinetic time-courses, and pharmacokinetic parameters (e.g. clearance, half-life, area under the curve). We demonstrate via multiple applications how the data set can be used to solidify existing knowledge and gain new insights relevant for metabolic phenotyping and liver function testing based on caffeine. Specifically, we analyzed (i) the alteration of caffeine pharmacokinetics with smoking and use of oral contraceptives; (ii) drug-drug interactions with caffeine as possible confounding factors of caffeine pharmacokinetics or source of adverse effects; (iii) alteration of caffeine pharmacokinetics in disease; and (iv) the applicability of caffeine as a salivary test substance by comparison of plasma and saliva data. In conclusion, our data set and analyses provide important resources which could enable more accurate caffeine-based metabolic phenotyping and liver function testing.

pharmacology and toxicology